# Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis

> **NCT03553615** · PHASE2 · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Ivermectin Pill

## Key facts

- **NCT ID:** NCT03553615
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2030-12-01
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Limited clinical capacity
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03553615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03553615, "Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT03553615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*